Neoadjuvant chemotherapy enhanced recruitment of CD8+ T cells, cytotoxic T cells, B cells, and granulocytes in the stroma of central tumor, but not in the invasive margin, which partly justified the small increase of immune infiltration in the overall tumor after chemotherapy. The gene discussed is CD8A; the disease is neoplasm.